Published in AIDS Care on May 24, 2011
Novel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York City. PLoS One (2012) 1.05
A prospective study of the onset of sexual behavior and sexual risk in youth perinatally infected with HIV. J Sex Res (2011) 1.03
Individual and contextual factors of sexual risk behavior in youth perinatally infected with HIV. AIDS Patient Care STDS (2012) 0.91
Substance use and the development of sexual risk behaviors in youth perinatally exposed to HIV. J Pediatr Psychol (2014) 0.88
Self-Efficacy for Sexual Risk Reduction and Partner HIV Status as Correlates of Sexual Risk Behavior Among HIV-Positive Adolescent Girls and Women. AIDS Patient Care STDS (2015) 0.85
EVOLUTION--taking charge and growing stronger: the design, acceptability, and feasibility of a secondary prevention empowerment intervention for young women living with HIV. AIDS Patient Care STDS (2014) 0.82
The reproductive health behaviors of HIV-infected young women in the United States: A literature review. AIDS Patient Care STDS (2013) 0.80
A Question of Love and Trust? The Role of Relationship Factors in Adolescent Sexual Decision Making. J Dev Behav Pediatr (2015) 0.75
HIV is always with me: men living with perinatally acquired HIV and planning their families. Open Access J Contracept (2017) 0.75
Two vignettes of adolescent sexual disclosure: guidance for HIV clinical practice. J Infect Prev (2016) 0.75
Whatever happened to qualitative description? Res Nurs Health (2000) 24.65
Changing AIDS-risk behavior. Psychol Bull (1992) 14.87
Application of the theory of gender and power to examine HIV-related exposures, risk factors, and effective interventions for women. Health Educ Behav (2000) 7.39
Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004. Am J Public Health (2006) 4.94
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 4.17
Sexual and reproductive health of persons aged 10-24 years - United States, 2002-2007. MMWR Surveill Summ (2009) 2.89
Psychosocial predictors of HIV-associated sexual behaviors and the efficacy of prevention interventions in adolescents at-risk for HIV infection: what works and what doesn't work? Psychosom Med (2008) 2.49
Patterns of condom use among adolescents: the impact of mother-adolescent communication. Am J Public Health (1998) 2.37
HIV superinfection. J Infect Dis (2005) 2.20
The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. AIDS (2009) 2.07
The efficacy of HIV/STI behavioral interventions for African American females in the United States: a meta-analysis. Am J Public Health (2009) 1.95
I wanna hold your hand: the progression of social, romantic and sexual events in adolescent relationships. Perspect Sex Reprod Health (2007) 1.82
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics (2009) 1.79
Social support and disclosure as predictors of mental health in HIV-positive youth. AIDS Patient Care STDS (2007) 1.77
"You've gotta know the community": minority women make recommendations about community-focused health research. Women Health (2008) 1.60
The relationship of unsafe sexual behavior and the characteristics of sexual partners of HIV infected and HIV uninfected adolescent females. J Adolesc Health (2001) 1.58
A randomized comparison of A-CASI and phone interviews to assess STD/HIV-related risk behaviors in teens. J Adolesc Health (2002) 1.58
Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health (2007) 1.53
Sexual behaviors and procreational intentions of adolescents and young adults with perinatally acquired human immunodeficiency virus infection: experience of an urban tertiary center. J Adolesc Health (2006) 1.52
A longitudinal study of adolescents with perinatally or transfusion acquired HIV infection: sexual knowledge, risk reduction self-efficacy and sexual behavior. AIDS Behav (2007) 1.51
Sexual behavior and perceived peer norms: comparing perinatally HIV-infected and HIV-affected youth. J Youth Adolesc (2008) 1.37
Disclosure of serostatus by HIV infected youth: the experience of the REACH study. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health (2001) 1.33
Socio-cultural influences on young people's sexual development. Soc Sci Med (2004) 1.30
Young, seropositive, and pregnant: epidemiologic and psychosocial perspectives on pregnant adolescents with human immunodeficiency virus infection. Am J Obstet Gynecol (2007) 1.21
The relationship-oriented information-motivation-behavioral skills model: a multilevel structural equation model among dyads. AIDS Behav (2008) 1.20
Pregnancy in perinatally HIV-infected adolescents. J Adolesc Health (2006) 1.19
Association between condom use at sexual debut and subsequent sexual trajectories: a longitudinal study using biomarkers. Am J Public Health (2007) 1.17
Recruiting and retaining couples for an HIV prevention intervention: lessons learned from the PARTNERS project. Health Educ Res (2006) 0.96
Sexual self-concept and sexual risk-taking. J Adolesc (1997) 0.93
Having sex and condom use: potential risks and benefits reported by young, sexually inexperienced adolescents. J Adolesc Health (2006) 0.90
Maintaining safer sex behaviours in HIV-infected adolescents with haemophilia. The Hemophilia Behavioral Evaluative Intervention Project Committee. AIDS Care (1996) 0.79
Disclosure of an HIV diagnosis to children: history, current research, and future directions. J Dev Behav Pediatr (2007) 2.87
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics (2002) 2.83
Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters. J Child Psychol Psychiatry (2009) 2.57
Sexual and drug use behavior in perinatally HIV-infected youth: mental health and family influences. J Am Acad Child Adolesc Psychiatry (2009) 1.88
A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics (2006) 1.78
Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J Virol (2002) 1.74
Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377. Pediatrics (2003) 1.57
Keeping the spirit of community partnerships alive in the scale up of HIV/AIDS prevention: critical reflections on the roll out of DEBI (Diffusion of Effective Behavioral Interventions). Am J Community Psychol (2008) 1.55
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. AIDS (2007) 1.53
STUDY OF THE PREVALENCE OF AUTOIMMUNE THYROID DISEASE IN WOMEN WITH BREAST CANCER. Endocr Pract (2015) 1.47
Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics (2005) 1.39
The impact of perinatal HIV infection on older school-aged children's and adolescents' receptive language and word recognition skills. AIDS Patient Care STDS (2009) 1.38
Sexual behavior and perceived peer norms: comparing perinatally HIV-infected and HIV-affected youth. J Youth Adolesc (2008) 1.37
HIV prevention and primary care for transgender women in a community-based clinic. J Assoc Nurses AIDS Care (2009) 1.28
HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol (2003) 1.25
Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy. Arch Pediatr Adolesc Med (2002) 1.25
Depressive symptomatology among HIV-positive women in the era of HAART: a stress and coping model. Am J Community Psychol (2006) 1.22
Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth. AIDS Care (2012) 1.21
A comparison of audio computer-assisted self-interviews to face-to-face interviews of sexual behavior among perinatally HIV-exposed youth. Arch Sex Behav (2011) 1.17
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1. Clin Infect Dis (2002) 1.16
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med (2011) 1.14
Understanding Motivators and Challenges to Involving Urban Parents as Collaborators in HIV Prevention Research Efforts. Soc Work Ment Health (2008) 1.07
Pediatric HIV medication adherence: the views of medical providers from two primary care programs. J Pediatr Health Care (2003) 1.02
Multiple dimensions of HIV stigma and psychological distress among Asians and Pacific Islanders living with HIV illness. AIDS Behav (2005) 1.01
Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus. J Immunol (2002) 1.00
Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years. Clin Infect Dis (2013) 0.97
Reproductive health decision-making in perinatally HIV-infected adolescents and young adults. Matern Child Health J (2013) 0.95
Brief report: language ability and school functioning of youth perinatally infected with HIV. J Pediatr Health Care (2008) 0.94
The development and implementation of theory-driven programs capable of addressing poverty-impacted children's health, mental health, and prevention needs: CHAMP and CHAMP+, evidence-informed, family-based interventions to address HIV risk and care. J Clin Child Adolesc Psychol (2014) 0.94
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1. J Infect Dis (2005) 0.94
Individual and contextual factors of sexual risk behavior in youth perinatally infected with HIV. AIDS Patient Care STDS (2012) 0.91
Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects. Pediatrics (2008) 0.89
Perceptions of adolescents' sexual behavior among mothers living with and without HIV: does dyadic sex communication matter? Arch Sex Behav (2008) 0.88
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption. J Acquir Immune Defic Syndr (2011) 0.88
Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patients. Antimicrob Agents Chemother (2011) 0.87
Prevalence of oral lesions and percent CD4+ T-lymphocytes in HIV-infected children on antiretroviral therapy. AIDS Patient Care STDS (2003) 0.85
Psychological distress, substance use, and adjustment among parents living with HIV. J Am Board Fam Pract (2005) 0.84
Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection. Pharmacotherapy (2004) 0.82
Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children. Pediatr Infect Dis J (2004) 0.82
Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children. J Acquir Immune Defic Syndr (2006) 0.82
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403. Pediatr Infect Dis J (2005) 0.81
Brief report: assessing adherence to pediatric antiretroviral regimens using the 24-hour recall interview. J Pediatr Psychol (2006) 0.81
Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV. Clin Infect Dis (2016) 0.81
HIV treatment adherence measurement and reporting concordance in youth with perinatally acquired HIV infection and their caregivers. AIDS Patient Care STDS (2015) 0.80
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2002) 0.80
Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years. Ann Allergy Asthma Immunol (2013) 0.79
Use of Integrase Inhibitors in HIV-Infected Children and Adolescents. Drugs (2015) 0.79
Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children. Pediatr Infect Dis J (2002) 0.79
Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents. AIDS (2015) 0.79
Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure. AIDS Res Hum Retroviruses (2012) 0.78
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2010) 0.78
Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children. Antivir Ther (2002) 0.77
Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection. Pediatr Infect Dis J (2002) 0.77
Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J (2009) 0.77
Use of nucleoside reverse transcriptase inhibitor-only regimens in HIV-infected children and adolescents. Pediatr Infect Dis J (2013) 0.76
Association between skin testing in the pediatric emergency department and adherence to follow-up in children with asthma. Ann Allergy Asthma Immunol (2009) 0.76
Fear of repeated injections in children younger than 4 years receiving subcutaneous allergy immunotherapy. Ann Allergy Asthma Immunol (2012) 0.76
Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children. Clin Infect Dis (2005) 0.76
Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults. Pediatr Infect Dis J (2016) 0.75
Pinto responds. Am J Public Health (2013) 0.75
Midwifery in the media. Midwifery Today Int Midwife (2004) 0.75
Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093. Pediatr Infect Dis J (2015) 0.75
Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young Adults. Pediatr Infect Dis J (2016) 0.75
Effects of Pilates exercises on health-related quality of life in individuals with juvenile idiopathic arthritis. Arch Phys Med Rehabil (2013) 0.75
Dental visits by pediatric HIV-infected medical patients. N Y State Dent J (2003) 0.75